Theravie Pharma raises $750K in October 2026 SEC filing
Theravie Pharma
- Raised in SEC filings
- $750K
- Filings
- 1
- Latest est. round
- Pre-seed/Seed
- Incorporated
- 2025
- Industry
- Biotechnology
- Based in
- CA
Theravie Pharma, incorporated in 2025, first filed with the SEC in October 2026. This filing reported $750K sold in an estimated Pre-seed/Seed round, with the first sale occurring in September 2026.
The latest filing names Samia Almoughrabie as an Executive Officer and Director, and Richard Gallo as an Executive Officer and Director. Find your role first does not track Theravie Pharma's open roles at this time.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-09-29 | $750K | Pre-seed/Seed |
Named in the latest filing
- Samia Almoughrabie
- Richard Gallo
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR